...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A simple, sensitive, and high-throughput LC-APCI-MS/MS method for simultaneous determination of vitamin K 1 , vitamin K 1 2,3-epoxide in human plasma and its application to a clinical pharmacodynamic study of warfarin
【24h】

A simple, sensitive, and high-throughput LC-APCI-MS/MS method for simultaneous determination of vitamin K 1 , vitamin K 1 2,3-epoxide in human plasma and its application to a clinical pharmacodynamic study of warfarin

机译:一种简单,敏感和高通量的LC-APCI-MS / MS方法,用于同时测定人血浆中的维生素K1,维生素K12,3-环氧化物及其在华法林的临床药效学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Warfarin exerts its anticoagulation activity by blocking the vitamin K-epoxide cycle. A quantitative understanding of how warfarin and related genes interact with the vitamin K-epoxide cycle and the associated change of coagulation activity in the human body may help study the pharmacodynamics of warfarin. The plasma concentration of vitamin K1(VK1) and vitamin K12,3-epoxide (VK1O) could reflect the status of vitamin K-epoxide cycle. However, their determination is a challenging task due to their extremely low concentrations in human plasma and the severe interferences caused by co-extracted lipids. In this study, we developed an LC-APCI-MS/MS method for the simultaneous determination of VK1and VK1O in human plasma using stable deuterium-labeled vitamin K1(vitamin K1-d7) as the internal standard (IS). Plasma samples were prepared through protein denaturation followed by one-step liquid extraction with cyclohexane. Chromatographic separation of analytes from isobaric interferences and endogenous ion suppressor was performed on a Synergi Hydro-RP column (150?mm?×?4.6?mm, 4?μm) under the reversed-phase condition with isocratic elution. The selective reaction monitoring (SRM) transitions were chosen asm/z?=?451.5→187.3 for VK1,m/z?=?467.5→161.2 for VK1O, andm/z?=?458.6→194.3 for IS in APCI positive mode. The assay was linear in the range of 100–10,000?pg/mL for the two analytes and achieved considerable extraction recoveries (87.8–93.3%, 91.0–96.9%, and 92.0% for VK1, VK1O, and IS, respectively), negligible matrix effects (93.6–96.0%, 96.3–100.1%, and 95.5%), and high selectivity with a small sample volume requirement (0.2?mL) and short run time (15?min). The validated method was successfully applied in a clinical pharmacodynamic study of warfarin, and the clotting activity was found to be negatively correlated with the plasma concentration ratio of VK1O to VK1.
机译:Warfarin通过阻断维生素K-环氧循环来施加抗凝血活性。定量了解华法林和相关基因如何与维生素K-环氧化物循环相互作用以及人体凝血活性的相关变化可能有助于研究华法林的药效学。维生素K1(VK1)和维生素K12,3-环氧化物(VK1O)的血浆浓度可反映维生素K-环氧循环的状态。然而,由于它们在人血浆中极低的浓度和由共提取的脂质引起的严重干扰,他们的决心是一个具有挑战性的任务。在该研究中,我们开发了一种用于使用稳定的氘标记的维生素K1(维生素K1-D7)同时测定人血浆中的VK1和Vκ1o作为内标(是)的LC-APCI-MS / MS方法。通过蛋白质变性制备等离子体样品,然后用环己烷进行一步液萃取。在具有等级洗脱的反相条件下,在Synergi Hydro-RP柱(150Ω××4.6×4.6×4.6μm,4μm)下进行分析物的分析物的分析物分离。选择性反应监测(SRM)转变被选为ASM / Z?=Δ= 451.5→187.3,用于VK1,M / Z?= 467.5→161.2用于VK1O,ANDM / Z?=?458.6→194.3为APCI正模式。对于两种分析物的100-10,000×pg / ml的测定线性为100-10,000×pg / ml,并且分别达到了相当大的提取回收率(87.8-93.3%,91.0-96.9%,91.0-96.9%,分别为92.0%,并且是忽略的基质效应(93.6-96.0%,96.3-100.1%和95.5%),具有小的样品体积要求(0.2Ωml)和短的运行时间(15?min)的高选择性。经过验证的方法已成功应用于华法林的临床药效学研究,发现凝血活性与VK1O至VK1的血浆浓度比负相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号